Cardiff Oncology
CRDF
60 hedge funds and large institutions have $59.4M invested in Cardiff Oncology in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 10 reducing their positions, and 16 closing their positions.
220% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 10
63% more call options, than puts
Call options by funds: $2.08M | Put options by funds: $1.27M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 66 → 60 (-6)
33% less capital invested
Capital invested by funds: $88.7M → $59.4M (-$29.3M)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$4M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.47M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$1.85M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.59M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$2.95M |
| 2 |
Renaissance Technologies
New York
|
-$1.34M |
| 3 |
Goldman Sachs
New York
|
-$1.18M |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$1.08M |
| 5 |
FAM
Fred Alger Management
New York
|
-$671K |
CRDF Hedge Fund Activity: Q3 2015 in Review
60 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q3 2015, worth a combined $59.4M — down 33% from $88.7M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of CRDF and 10 opened new positions — a net loss of 6 holders — while 10 trimmed existing stakes and 32 added.
The largest buyer was Tekla Capital Management, opening a new position worth an estimated $4M. The largest seller was EAM Investors, exiting entirely with an estimated $2.95M sold.
- 60 institutional investors held Cardiff Oncology (CRDF) as of Q3 2015, down from 66 in Q2 2015.
- Funds reported $59.4M of Cardiff Oncology stock for Q3 2015, down 33% quarter-over-quarter.
- 10 funds opened new Cardiff Oncology positions in Q3 2015 and 16 closed out, a net change of -6 holders.
- The largest Cardiff Oncology buyer in Q3 2015 was Tekla Capital Management, an estimated $4M added.
- The largest Cardiff Oncology seller in Q3 2015 was EAM Investors, an estimated $2.95M sold.
Based on aggregated 13F filings for Q3 2015.